Professional Summary »
Specializing In »
Practice Locations »
Referring Physicians »
Specializing In
- Psychological Conditions
Professional Summary
Education & Certifications
- PhD Training: Pacific Graduate School of Psychology (2002) CA
- Fellowship: VA Medical Center Palo Alto (2003) CA
- Internship: Laguna Honda Hospital (2002) CA
Publications
-
Estrogen and response to sertraline in postmenopausal women with major depressive disorder: A pilot study
Rasgon, N. L., Dunkin, J., Fairbanks, L., Altshuler, L. L., Troung, C., Elman, S., … Rapkin, A. (2007). Estrogen and response to sertraline in postmenopausal women with major depressive disorder: A pilot study. JOURNAL OF PSYCHIATRIC RESEARCH, 41(3-4), 338–43. -
Mood and neuropsychological changes in women with midlife depression treated with escitalopram
Wroolie, T. E., Williams, K. E., Keller, J., Zappert, L. N., Shelton, S. D., Kenna, H. A., … Rasgon, N. L. (2006). Mood and neuropsychological changes in women with midlife depression treated with escitalopram. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 26(4), 361–66. -
Cognitive effects of memantine in postmenopausal women at risk of dementia: a pilot study
Wroolie, T. E., Kenna, H. A., Williams, K. E., Powers, B. N., Holcomb, M., Lazzeroni, L., & Rasgon, N. L. (2009). Cognitive effects of memantine in postmenopausal women at risk of dementia: a pilot study. ACTA NEUROLOGICA SCANDINAVICA, 119(3), 172–79. -
Insulin resistance and hippocampal volume in women at risk for Alzheimer's disease
Rasgon, N. L., Kenna, H. A., Wroolie, T. E., Kelley, R., Silverman, D., Brooks, J., … Reiss, A. (2011). Insulin resistance and hippocampal volume in women at risk for Alzheimer's disease. NEUROBIOLOGY OF AGING, 32(11), 1942–48. -
Rosiglitazone Add-On in Treatment of Depressed Patients with Insulin Resistance: a Pilot Study
Rasgon, N. L., Kenna, H. A., Williams, K. E., Powers, B., Wroolie, T., & Schatzberg, A. F. (2010). Rosiglitazone Add-On in Treatment of Depressed Patients with Insulin Resistance: a Pilot Study. THESCIENTIFICWORLDJOURNAL, 10, 321–28. -
Differences in regional brain metabolism associated with specific formulations of hormone therapy in postmenopausal women at risk for AD
Silverman, D. H. S., Geist, C. L., Kenna, H. A., Williams, K., Wroolie, T., Powers, B., … Rasgon, N. L. (2011). Differences in regional brain metabolism associated with specific formulations of hormone therapy in postmenopausal women at risk for AD. PSYCHONEUROENDOCRINOLOGY, 36(4), 502–13. -
Differences in Verbal Memory Performance in Postmenopausal Women Receiving Hormone Therapy: 17 beta-Estradiol Versus Conjugated Equine Estrogens
Wroolie, T. E., Kenna, H. A., Williams, K. E., Powers, B. N., Holcomb, M., Khaylis, A., & Rasgon, N. L. (2011). Differences in Verbal Memory Performance in Postmenopausal Women Receiving Hormone Therapy: 17 beta-Estradiol Versus Conjugated Equine Estrogens. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 19(9), 792–802. -
Fasting plasma insulin and the default mode network in women at risk for Alzheimer's disease
Kenna, H., Hoeft, F., Kelley, R., Wroolie, T., Demuth, B., Reiss, A., & Rasgon, N. (2013). Fasting plasma insulin and the default mode network in women at risk for Alzheimer's disease. NEUROBIOLOGY OF AGING, 34(3), 641–49. -
Topiramate: Effects on cognition in patients with epilepsy, migraine headache and obesity.
Sommer, B. R., Mitchell, E. L., & Wroolie, T. E. (2013). Topiramate: Effects on cognition in patients with epilepsy, migraine headache and obesity. Therapeutic Advances in Neurological Disorders, 6(4), 211–27. -
Prospective randomized trial to assess effects of continuing hormone therapy on cerebral function in postmenopausal women at risk for dementia.
Rasgon, N. L., Geist, C. L., Kenna, H. A., Wroolie, T. E., Williams, K. E., & Silverman, D. H. S. (2014). Prospective randomized trial to assess effects of continuing hormone therapy on cerebral function in postmenopausal women at risk for dementia. PloS One, 9(3). -
Insulin resistance and medial prefrontal gyrus metabolism in women receiving hormone therapy.
Rasgon, N. L., Kenna, H. A., Wroolie, T. E., Williams, K. E., DeMuth, B. N., & Silverman, D. H. S. (2014). Insulin resistance and medial prefrontal gyrus metabolism in women receiving hormone therapy. Psychiatry Research, 223(1), 28–36. -
Insulin resistance and medial prefrontal gyrus metabolism in women receiving hormone therapy
Rasgon, N. L., Kenna, H. A., Wroolie, T. E., Williams, K. E., DeMuth, B. N., & Silverman, D. H. S. (2014). Insulin resistance and medial prefrontal gyrus metabolism in women receiving hormone therapy. PSYCHIATRY RESEARCH-NEUROIMAGING, 223(1), 28–36. -
Prospective randomized trial to assess effects of continuing hormone therapy on cerebral function in postmenopausal women at risk for dementia.
Rasgon, N. L., Geist, C. L., Kenna, H. A., Wroolie, T. E., Williams, K. E., & Silverman, D. H. S. (2014). Prospective randomized trial to assess effects of continuing hormone therapy on cerebral function in postmenopausal women at risk for dementia. PloS One, 9(3). -
Association between insulin resistance and cognition in patients with depressive disorders: Exploratory analyses into age-specific effects
Wroolie, T. E., Kenna, H. A., Singh, M. K., & Rasgon, N. L. (2015). Association between insulin resistance and cognition in patients with depressive disorders: Exploratory analyses into age-specific effects. JOURNAL OF PSYCHIATRIC RESEARCH, 60, 65–72. -
Association between insulin resistance and cognition in patients with depressive disorders: exploratory analyses into age-specific effects.
Wroolie, T. E., Kenna, H. A., Singh, M. K., & Rasgon, N. L. (2015). Association between insulin resistance and cognition in patients with depressive disorders: exploratory analyses into age-specific effects. Journal of Psychiatric Research, 60, 65–72. -
Cognitive Effects of Hormone Therapy Continuation or Discontinuation in a Sample of Women at Risk for Alzheimer Disease.
Wroolie, T. E., Kenna, H. A., Williams, K. E., & Rasgon, N. L. (2015). Cognitive Effects of Hormone Therapy Continuation or Discontinuation in a Sample of Women at Risk for Alzheimer Disease. American Journal of Geriatric Psychiatry , 23(11), 1117–26. -
Adjuvant pioglitazone for unremitted depression: Clinical correlates of treatment response
Lin, K. W., Wroolie, T. E., Robakis, T., & Rasgon, N. L. (2015). Adjuvant pioglitazone for unremitted depression: Clinical correlates of treatment response. PSYCHIATRY RESEARCH, 230(3), 846–52. -
Allostatic Load Predictors of Treatment Response in Patients With Unremitted Depression
Rasgon, N., Watson, K., Singh, M., Wroolie, T., Myoraku, A., & Roat-Shumway, S. (2018). Allostatic Load Predictors of Treatment Response in Patients With Unremitted Depression. BIOLOGICAL PSYCHIATRY, 83(9), S36–S37. -
Determinants of cognitive function in individuals with type 2 diabetes mellitus: A meta-analysis
Mansur, R. B., Lee, Y., Zhou, A. J., Carmona, N. E., Cha, D. S., Rosenblat, J. D., … McIntyre, R. S. (2018). Determinants of cognitive function in individuals with type 2 diabetes mellitus: A meta-analysis. ANNALS OF CLINICAL PSYCHIATRY, 30(1), 38–50. -
Neural correlates of liraglutide effects in persons at risk for Alzheimer's Disease.
Watson, K. T., Wroolie, T. E., Tong, G., Foland-Ross, L. C., Frangou, S., Singh, M., … Rasgon, N. L. (2018). Neural correlates of liraglutide effects in persons at risk for Alzheimer's Disease. Behavioural Brain Research. -
Early life adversity blunts responses to pioglitazone in depressed, overweight adults.
Robakis, T. K., Watson-Lin, K., Wroolie, T. E., Myoraku, A., Nasca, C., Bigio, B., … Rasgon, N. L. (2018). Early life adversity blunts responses to pioglitazone in depressed, overweight adults. European Psychiatry : the Journal of the Association of European Psychiatrists, 55, 4–9. -
Childhood trauma and insulin resistance in patients suffering from depressive disorders.
Nasca, C., Watson, K., Bigio, B., Robakis, T., Myoraku, A., Wroolie, T., … Rasgon, N. (2019). Childhood trauma and insulin resistance in patients suffering from depressive disorders. Experimental Neurology. -
Adjuvant pioglitazone for unremitted depression: Clinical correlates of treatment response.
Lin, K. W., Wroolie, T. E., Robakis, T., & Rasgon, N. L. (2015). Adjuvant pioglitazone for unremitted depression: Clinical correlates of treatment response. Psychiatry Research, 230(3), 846–52. -
Childhood trauma and insulin resistance in patients suffering from depressive disorders
Nasca, C., Watson-Lin, K., Bigio, B., Robakis, T. K., Myoraku, A., Wroolie, T. E., … Rasgon, N. (2019). Childhood trauma and insulin resistance in patients suffering from depressive disorders. EXPERIMENTAL NEUROLOGY, 315, 15–20. -
The Effects of Statins on Cognition in Older Women at Genetic Risk for Alzheimer's Disease
Wroolie, T., Roat-Shumway, S., Watson, K., & Rasgon, N. (2019). The Effects of Statins on Cognition in Older Women at Genetic Risk for Alzheimer's Disease. NEUROPSYCHOPHARMACOLOGY, 44(SUPPL 1), 386. -
Effects of LDL Cholesterol and Statin Use on Verbal Learning and Memory in Older Adults at Genetic Risk for Alzheimer's Disease.
Wroolie, T., Roat-Shumway, S., Watson, K., Reiman, E., & Rasgon, N. (2020). Effects of LDL Cholesterol and Statin Use on Verbal Learning and Memory in Older Adults at Genetic Risk for Alzheimer's Disease. Journal of Alzheimer's Disease : JAD. -
Neuropsychological Testing "I Sometimes Forget Things"
Wroolie, T. E., Cassidy-Eagle, E. L., & Dunn, L. B. (2020). Neuropsychological Testing "I Sometimes Forget Things". PRACTICAL STRATEGIES IN GERIATRIC MENTAL HEALTH: CASES AND APPROACHES, 251–64.
Practice Locations
Outpatient Psychiatry Clinic in Palo Alto Stanford, CA
Stanford, CA
Outpatient Psychiatry Clinic in Palo Alto
401 Quarry Road
Stanford , CA 94304
Make An Appointment More Clinic Information » Getting Here »Important Information about Our Organizations and Physician Affiliation
Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.
Referring Physicians
PHYSICIAN HELPLINE
Phone: 1-866-742-4811
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.
- Send referrals online
- Place radiology and lab orders
- View referral status
- Access medical records